Mucormycosis in COVID-19 patients: A cross-sectional study at IGIMS, Patna
Description
CONCLUSION: Post-COVID mucormycosis in India was primarily observed in patients with uncontrolled diabetes, immunodeficiency due to other comorbidities, and dysfunctional immune systems.
